ASX - Delayed Quote AUD

Avecho Biotechnology Limited (AVE.AX)

Compare
0.0030 0.0000 (0.00%)
At close: December 13 at 11:02:55 AM GMT+11

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
NameTitlePayExercisedYear Born
Dr. Paul Gavin BSc (Hons), Ph.D. Chief Executive Officer 259.65k -- --
Dr. Roksan Libinaki Ph.D. Chief Operating Officer 226.63k -- --
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary & CFO -- -- 1973

Avecho Biotechnology Limited

2A Westall Road
Unit A8
Clayton, VIC 3168
Australia
61 3 9002 5000 https://avecho.com.au
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Avecho Biotechnology Limited, a biotechnology company, engages in the development and commercialization of human and animal health related products using its proprietary drug delivery system and Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. In addition, the company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. Further, it develops feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney for treatment of osteoarthritis. The company was incorporated in 1992 and is based in Clayton, Australia.

Corporate Governance

Avecho Biotechnology Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 26, 2025 at 6:34 AM UTC - March 3, 2025 at 6:34 AM UTC

Avecho Biotechnology Limited Earnings Date

Recent Events

May 19, 1997 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

BIT.AX Biotron Limited
0.0170
-5.56%
 
BTC.AX BTC Health Limited
0.0660
-1.49%
 
ANR.AX Anatara Lifesciences Ltd
0.0470
+2.17%
 
1AI.AX Algorae Pharmaceuticals Limited
0.0080
0.00%
 
CHM.AX Chimeric Therapeutics Limited
0.0060
0.00%
 
ATX.AX Amplia Therapeutics Limited
0.0860
-1.15%
 
1AD.AX AdAlta Limited
0.0170
-5.56%
 
CMB.AX Cambium Bio Limited
0.4400
-18.52%
 
AGN.AX Argenica Therapeutics Limited
0.6850
-0.72%
 
NOX.AX Noxopharm Limited
0.1000
0.00%